Autopsy report · NCT01171456
Early Intervention for Gestational Diabetes
Cause of deathFunding or business
“Insufficient funding for enrollment of patients. The invesitgators realized the study could not be performed.”
Life of this trial
- Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.
Vital statistics
- Status
- Withdrawn
- Phase
- Na
- Sponsor
- Intermountain Health Care, Inc.
- Sponsor type
- University, hospital or other
- Conditions
- Gestational Diabetes Mellitus
- Interventions
- Metformin; Placebo
- Participants
- 0
- Sites
- 1
- Countries
- United States
Trials that died the same way
- Effect of Rasagiline on Balance in Parkinson's Disease as Measured by Computerized Posturography
“Funding for the study could not be obtained.” - Evaluation of the Efficacy of Bio-K+ Cl-1285® In the Nasal Decolonization of Methicillin Resistant Staphylococcus Aureus (MRSA) Carrier Patients
“Unable to recruit patients to continue on with the study.” - Brain and Behavioral Influences on Motor Skill Learning in Multiple Sclerosis
“This study did not receive funding and was therefore withdrawn prior to enrollment of participants.” - Impact of Nutrition and Swallowing Function of Head and Neck Cancer Patients During the Course of Treatment
“The study did not receive funding.” - Safety and Effectiveness of Combined LED Light for the Treatment of Mild to Moderate Plaque Type Psoriasis Vulgaris
“Lack of funding and sponsor decided to not pursue clinical trial”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.